Clinical Study
The Mode of Pretransplant Dialysis Does Not Affect Postrenal Transplant Outcomes in African Americans
Table 1
Donor and recipient demographics.
| | | Hemodialysis
| Peritoneal dialysis
| value |
| | Kidney donor | | | | | Age (yr) | 39.8 ± 14.7 | 41.2 ± 16.9 | ns | | Males | 167 (49.3%) | 38 (61.3%) | ns | | African American | 134 (39.5%) | 16 (25.8%) | = 0.046 | | SCD | 210 (61.9%) | 41 (66.1%) | ns | | ECD | 23 (6.8%) | 4 (4.5%) | ns | | DCD | 8 (2.4%) | 1 (1.6%) | ns | | Living donors | 98 (28.9%) | 16 (25.8%) | ns | | Kidney recipient | | | | | Age (yr) | 47.6 ± 12.7 | 44 ± 13.8 | = 0.04 | | Males | 190 (56%) | 24 (38.7%) | = 0.01 | | African American | 254 (74.9%) | 39 (62.9%) | ns | | Time on dialysis (mo) | 44.0 ± 39.2 | 35.2 ± 32.8 | ns | | PRA | 26.9 ± 36.3 | 23.7 ± 34.8 | ns | | HLA mismatch | 4 ± 1.6 | 4 ± 1.7 | ns | | CIT (hr) | 10.1 ± 9.7 | 12.4 ± 11.0 | ns | | WIT (min) | 30.6 ± 8.8 | 31.7 ± 11.7 | ns |
|
|
SCD: standard criteria donors, ECD: extended criteria donors, DCD: donation after cardiac death, PRA: panel reactive antibodies, HLA: human leukocyte antigen, CIT: cold ischemia time, WIT: warm ischemia time, ns: not significant ( > 0.05).
|
